Could an arthritis drug fix Post-Surgery blood sugar crashes?

NCT ID NCT07580079

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether Anakinra, a drug that reduces inflammation, can prevent dangerous drops in blood sugar after meals in a patient who had his stomach removed. The 52-year-old man also has kidney failure and needs dialysis. Over 10 weeks, he will receive either Anakinra or a placebo during dialysis, and his blood sugar will be tracked continuously. The goal is to see if the drug reduces the severity and frequency of low blood sugar episodes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Anakinra (a drug that blocks inflammation)
What this could lead to
If it works, this could point toward a treatment for severe low blood sugar after stomach surgery.
What could go wrong
This is a very early, single-patient study, so results may not apply to others. The drug may not work or could cause side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE (ESRD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kantonsspital Olten

    Olten, Canton of Solothurn, 4600, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.